Human urinary phthalate metabolites level and main semen parameters, sperm chromatin structure, sperm aneuploidy and reproductive hormones

Reproductive Toxicology

Volumn 42, Issue , 2013, Pages 232-241

  Jurewicz, Joanna ^a   Radwan, Michał ^b   Sobala, Wojciech ^a   Ligocka, Danuta ^a   Radwan, Paweł ^b   Bochenek, Michał ^c   Hawuła, Wanda ^d   Jakubowski, Lucjusz ^d   Hanke, Wojciech ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^b Gameta Hospital   (Poland)

^c NATIONAL RESEARCH INSTITUTE OF ANIMAL PRODUCTION   (Poland)

^d POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Exposure to phthalates; Semen quality; Sperm aneuploidy; Sperm chromatin structure

Indexed keywords

ESTRADIOL; FOLLITROPIN; MONO N BUTYL PHTHALATE; MONO(2 ETHYL 5 HYDROXYHEXYL)PHTHALATE; MONOETHYLHEXYLPHTHALATE; MONOETHYLPHTHALATE; MONOISONONYL(DIISOBUTYL PHTHALATE); PHTHALIC ACID; SEX HORMONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; ANEUPLOIDY; ARTICLE; CHROMATIN STRUCTURE; DNA DAMAGE; DNA FRAGMENTATION; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NUMERICAL CHROMOSOME ABERRATION; OLIGOSPERMIA; SEMEN ABNORMALITY; SEMEN ANALYSIS; SPERM; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; URINALYSIS;

EXPOSURE TO PHTHALATES; SEMEN QUALITY; SPERM ANEUPLOIDY; SPERM CHROMATIN STRUCTURE;

ADULT; ANEUPLOIDY; CHROMATIN; ENVIRONMENTAL POLLUTANTS; ESTRADIOL; FOLLICLE STIMULATING HORMONE; HUMANS; MALE; PHTHALIC ACIDS; SEMEN; SPERM COUNT; SPERM MOTILITY; SPERMATOZOA; TESTOSTERONE; YOUNG ADULT;

EID: 84887161934     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2013.10.001     Document Type: Article

References (63)

1. Koch H.M., Calafat A.M. Human body burdens of chemicals used in plastic manufacture. Philos Trans R Soc Lond B Biol Sci 2009, 364(July (1526)):2063-2078.
2. Meeker J.D., Sathyanarayana S., Swan S.H. Phthalates and other additives in plastics: human exposure and associated health outcomes. Philos Trans R Soc Lond B Biol Sci 2009, 364(July (1526)):2097-2113.
3. ATSDR Toxicological Profile for Diethyl phthalate (DEP). Agency for toxic substances and disease registry. Atlanta, GA; 1995.
4. ATSDR Toxicological Profile for di-n-butyl phthalate (DBP). Agency for toxic substances and disease registry. Atlanta, GA; 2001.
5. Blount B.C., Silva M.J., Caudill S.P., Needham L.L., Pirkle J.L., Sampson E.J., et al. Levels of seven urinary phthalate metabolites in a human reference population. Environ Health Perspect 2000, 10(108):9799-9882.
6. Hauser R., Calafat A. Phthalates and human health. Occup Environ Med 2005, 62(11):806-818.
7. Koch H., Bolt H., Preuss R., Angerer J. New metabolites of di(2-ethylhexyl) phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP. Arch Toxicol 2005, 79(7):367-376.
8. Lorber M., Angerer J., Koch H. A simple pharmacokinetic model to characterize exposure of Americans to di-2-ethylhexyl phthalate. J Expo Sci Environ Epidemiol 2009, 20(1):38-53.
9. Silva M., Barr D., Reidy J., Kato K., Malek N., Hodge C., et al. Glucuronidation patterns of common urinary and serum monoester phthalate metabolites. Arch Toxicol 2003, 77(10):561-567.
10. Gray L.E., Ostby J., Furr J., Price M., Veeramachaneni D.N., Parks L. Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol Sci 2000, 58:350-365.
11. Mylchreest E., Cattley R., Foster P. Male reproductive tract malformations in rats following gestational and lactational exposure to di-(n-butyl)-phthalate: an antiandrogenic mechanism?. Toxicol Sci 1998, 43:47-60.
12. Arcadi F.A., Costa C., Imperatore C., Marchese A., Rapisarda A., Salemi M., et al. Oral toxicity of bis(2-ethylhexyl) phthalate during pregnancy and suckling in the Long-Evans rat. Food Chem Toxicol 1998, 36:963-970.
13. Foster P.M., Mylchreest E., Gaido K.W., Sar M. Effects of phthalate esters on the developing reproductive tract of male rats. Hum Reprod Update 2001, 231-235.
14. Moore R.W., Rudy T.A., Lin T.M., Ko K., Peterson R.E. Abnormalities of sexual development in male rats with in utero and lactational exposure to the antiandrogenic plasticizer di(2-ethylhexyl)phthalate. Environ Health Perspect 2001, 109:229-237.
15. Tandon R., Seth P.K., Srivastava S.P. Effect of in utero exposure to di(2-ethylhexyl)phthalate on rat testes. Indian J Exp Biol 1991, 29:1044-1046.
16. Parks L.G., Ostby J.S., Lambright C.R., Abbott B.D., Klinefelter G.R., Barlow N.J., et al. The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol Sci 2000, 58:339-349.
17. Foster P.M. Mode of action: impaired fetal Leydig cell function - effects on male reproductive development produced by certain phthalate esters. Crit Rev Toxicol 2005, 35:713-719.
18. Swan S.H., Main K.M., Liu F., Stewart S.L., Kruse S.L., Calafat A.M., et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 2005, 113:1056-1061.
19. Duty S.M., Calafat A.M., Silva M.J., Ryan L., Hauser R. Phthalate exposure and reproductive hormones in adult men. Hum Reprod 2005, 20(3):604-610.
20. Hauser R., Meeker J.D., Duty S., Silva M.J., Calafat A.M. Altered semen quality in relation to urinary concentrations of phthalate monoester and oxidative metabolites. Epidemiology 2006, 17:682-691.
21. Duty S.M., Silva M.J., Barr D.B., Brock J.W., Ryan L., Chen Z., et al. Phthalate exposure and human semen parameters. Epidemiology 2003, 14:269-277.
22. Duty S.M., Singh N.P., Silva M.J., Barr D.B., Brock J.W., Ryan L., et al. The relationship between environmental exposures to phthalates and DNA damage in human sperm using the neutral comet assay. Environ Health Perspect 2003, 111:1164-1169.
23. Jönsson A.G., Richthoff J., Rylander L., Giwercman A., Lars H. Urinary phthalate metabolities and biomarkers of reproductive function in young men. Epidemiology 2005, 16(4):487-493.
24. Wirth J.J., Rossano M.G., Potter R., Puscheck E., Daly D.C., Paneth N., et al. A pilot study associating urinary concentrations of phthalate metabolites and semen quality. Syst Biol Reprod Med 2008, 54(3):143-154.
25. Pant N., Shukla M., Patel K.D., Shukla Y., Mathur N., Gupta Y.K., et al. Correlation of phthalate exposures with semen quality. Toxicol Appl Pharmacol 2008, 231:112-116.
26. Zhang Y., Zheng L., Chen B. Phthalate exposure and human semen quality in Shanghai: a cross-sectional study. Biomed Environ Sci 2006, 19(3):205-209.
27. Pan G., Hanaoka T., Yoshimura M., Zhang S., Wang P., Tsukino H., et al. Decreased serum free testosterone in workers exposed to high levels of di-n-butyl phthalate (DBP) and di-2-ethylhexyl phthalate (DEHP): a cross-sectional study in China. Environ Health Perspect 2006, 114(11):1643-1648.
28. Mendiola J., Jørgensen N., Andersson A., Calafat A., Silva M., Redmon J., et al. Associations between urinary metabolites of di(2-ethylhexyl)phthalate and reproductive hormones in fertile men. Int J Androl 2010, 14:1-10.
29. WHO Laboratory Manual for the examination of human semen and sperm-cervical mucus interaction 1999, Cambridge University Press, Cambridge, UK. 4th ed.
30. Duty S.M., Calafat A.M., Silva M.J., Brock J.W., Ryan L., Chen Z., et al. The relationship between environmental exposure to phthalates and computer-aided sperm analysis motion parameters. J Androl 2004, 25(2):293-302.
31. Kruger T.F., Acosta A.A., Simmons K.F., Swanson R.J., Matta J.F., Oehninger S. Predictive value of abnormal sperm morphology in in vitro fertilization. Fertil Steril 1988, 49(1):112-117.
32. Messinis I.E., Loutradis D., Domali E., Kotsovassilis C.P., Papastergiopoulou L., Kallitsaris A., et al. Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment. Hum Reprod 2005, 20(11):3192-3197.
33. Raven G., de Jong F.H., Kaufman J.M., de Ronde W. In men, peripheral estradiol levels directly reflect the action of estrogens at the hypothalamo-pituitary level to inhibit gonadotropin secretion. J Clin Endocrinol Metabol 2006, 91(9):3324-3328.
34. ASRM Practice Committee Report on optimal evaluation of the infertile male. Fertil Steril 2006, 86(4):202-209.
35. Evenson D.P., Jost L.K., Marshall D., Zinaman M.J., Clegg E., Purvis K., et al. Utility of the sperm chromatin structure assay as a diagnostic and prognostic tool in the human fertility clinic. Hum Reprod 1999, 14(4):1039-1049.
36. Ushijima C., Kumasako Y., Kihaile P.E., Hirotsuru K., Utsunomiya T. Analysis of chromosomal abnormalities in human spermatozoa using multi-colour fluorescence in situ hybridization. Hum Reprod 2000, 15(5):1107-1111.
37. Koch H.M., Rossbach D., Drexlera H., Angerer J. Internal exposure of the general population to DEHP and other phthalates-determination of secondary and primary phthalate monoester metabolites in urine. Environ Res 2003, 93(2):177-185.
38. Preuss R., Koch H.M., Angerer J. Biological monitoring of the five major metabolites of di-(2- ethylhexyl)phthalate (DEHP) in human urine using column-switching liquid chromatographytandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 2005, 816:269-280.
39. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995, 57:289-300.
40. R Core TeamR: a language and environment for statistical computing 2013, R Foundation for Statistical Computing, Vienna, Austria. http://www.r-project.org/.
41. Li L.-H., Jester W.F., Orth J.M. Effects of relatively low levels of mono-(2-ethylhexyl) phthalate on cocultured sertoli cells and gonocytes from neonatal rats. Toxicol Appl Pharmacol 1998, 153:258-265.
42. Jarfelt K., Dalgaard M., Hass U., Borch J., Jacobsen H., Ladefoged O. Antiandrogenic effects in male rats perinatally exposed to a mixture of di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate. Reprod Toxicol 2005, 19:505-515.
43. Barlow N.J., Foster P.M. Pathogenesis of male reproductive tract lesions from gestation through adulthood following in utero exposure to di(n-butyl) phthalate. Toxicol Pathol 2003, 31(4):397-410.
44. Boberg J., Christiansen S., Axelstad M., Kledal T.S., Vinggaard A.M., Dalgaard M., et al. Reproductive and behavioral effects of diisononyl phthalate (DINP) in perinatally exposed rats. Reprod Toxicol 2011, 31(2):200-209.
45. Silva M.J., Kato K., Wolf C., Samandar E., Silva S.S., Gray E.L., et al. Urinary biomarkers of di-isononyl phthalate in rats. Toxicology 2006, 223(1-2):101-112.
46. Meeker J.D., Calafat A.M., Hauser R. Urinary metabolites of di(2-ethylhexyl)phthalate are associated with decreased steroid hormone levels in adult men. J Androl 2009, 30:287-297.
47. Hauser R., Meeker J.D., Singh N.P., Silva M.J., Ryan L., Duty S., et al. DNA damage in human sperm is related to urinary levels of phthalate monoester and oxidative metabolites. Hum Reprod 2007, 22:688-695.
48. Anderson D., Yu T.W., Hinçal F. Effect of some phthalate esters in human cells in the comet assay. Teratog Carcinog Mutagen 1999, 19(4):275-280.
49. Mein K.M., Mortensen G.K., Kaleva M.M., Boisen K.A., Damgaard I.N., Chellakooty M., et al. Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ Health Perspect 2006, 114:270-276.
50. Fabjan E., Hulzebos E., Mennes W., Piersma A.H. A category approach for reproductive effects of phthalates. Crit Rev Toxicol 2006, 36:695-726.
51. Borch J., Dalgaard M., Ladefoged O. Early testicular effects in rats perinatally exposed to DEHP in combination with DEHA-apoptosis assessment and immunohistochemical studies. Reprod Toxicol 2005, 19:517-525.
52. Fisher J.S., Macpherson S., Marchetti N., Sharpe R.M. Human "testicular dysgenesis syndrome": a possible model using in utero exposure of the rat to dibutyl phthalate. Hum Reprod 2003, 18:1383-1394.
53. Foster P.M., Mylchreest E., Gaido K.W., Sar M. Effects of phthalate esters on the developing reproductive tract of male rats. Hum Reprod Update 2001, 7:231-235.
54. Wilson V.S., Lambright C., Furr J., Ostby J., Wood C., Held G., et al. Phthalate ester-induced gubernacular lesions are associated with reduced insl3 gene expression in the fetal rat testis. Toxicol Lett 2004, 146:207-215.
55. Borch J., Axelstad M., Vinggaard A.M., Dalgaard M. Diisobutyl phthalate has comparable anti-androgenic effects to di-n-butyl phthalate in fetal rat testis. Toxicol Lett 2006, 163:183-190.
56. Sharpe R.M., Skakkebaek N.E. Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil Steril 2008, 89(2 Suppl.):e33-e38.
57. Mitchell R.T., Childs A.J., Anderson R.A., van den Driesche S., Saunders P.T., McKinnell C., et al. Do phthalates affect steroidogenesis by the human fetal testis? Exposure of human fetal testis xenografts to di-n-butyl phthalate. J Clin Endocrinol Metab 2012, 97(3):E341-E348.
58. Frederiksen H., Jørgensen N., Andersson A.M. Correlations between phthalate metabolites in urine, serum, and seminal plasma from young Danish men determined by isotope dilution liquid chromatography tandem mass spectrometry. J Anal Toxicol 2010, 34:400-410.
59. Dirven H.A., van den Broek P.H., Arends A.M., Nordkamp H.H., de Lepper A.J., Henderson P.T., et al. Metabolites of the plasticizer di(2-ethylhexyl)phthalate in urine samples of workers in polyvinyl chloride processing industries. Int Arch Occup Environ Health 1993, 64:549-554.
60. Hauser R., Meeker J.D., Park S., Silva M.J., Calafat A.M. Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ Health Perspect 2004, 112:1734-1740.
61. Silva M.J., Reidy J.A., Herbert A.R., Preau J.L., Needham L.L., Calafat A.M. Detection of phthalate metabolites in human amniotic fluid. Bull Environ Contam Toxicol 2004, 72:1226-1231.
62. Teitelbaum S.L., Britton J.A., Calafat A.M., Ye X., Silva M.J., Reidy J.A., et al. Temporal variability in urinary concentrations of phthalate metabolites, phytoestrogens and phenols among minority children in the United States. Environ Res 2008, 106(2):257-269.
63. Kristensen D.M., Hass U., Lesné L., Lottrup G., Jacobsen P.R., Desdoits-Lethimonier C., et al. Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod 2011, 26(1):235-244.